A Year In Review
The DDR field has experienced explosive growth, with the number of assets surging from 21 in 2014 to 398 in 2024. While established mechanisms continue to lead, new approaches and investments are driving further innovation in the space.
Stay ahead in this rapidly evolving landscape with our comprehensive review—uncover key clinical advancements, regulatory progress, and investment trends shaping the future of DDR therapies.
Download Now
Discover the latest breakthroughs in DDR development!
Beacon’s Landscape Review delves into the DDR drug pipeline, highlighting the resurgence of PARP inhibitor trials, the rise of ATR and WEE1-targeted therapies, and key clinical milestones. Gain insights into status changes, regulatory progress, and investment trends shaping the competitive landscape.
Report Contents
The Drug Landscape
A deep dive into the developmental statuses, phases and targets of DDR assets, as well as repair pathways.
The Trial Landscape
Analysis of DDR trials, including approval rates, targets, and disease indications.
The Commercial Landscape
A review of the DDR deals in 2024, analyzing the top 5 deals, deal types and active drug locations.
The Potential Future of DDR
Drugs to watch in DDR development and trial duration insights.
Regulatory Announcements
Key DDR approvals and regulatory developments.
You May Also Be Interested In...
DDR: 2024 Landscape Review
Microbiome: 2024 Landscape Review
TPD: 2024 Landscape Review
Strategic Insights for Biopharma Innovation Report
DDRi and ADC Combination Therapies Infographic
H1 2024 Oncolytic Viruses Landscape Review
Find Out More
Beacon is the ultimate decision-support tool for developers of complex therapeutics. By combining market-defining proprietary ontologies with the most accurate and comprehensive life sciences data, we offer our customers unmatched visibility into the drug, trial, and commercial landscapes. Each dataset is enriched with proprietary, hyper-targeted search and filtering capabilities tailored to specific modalities, in-depth data, and expert-curated market insights. With Beacon’s robust database solution, you can confidently navigate critical decisions and drive success.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
